Cryofibrinogen in Patients with Hepatitis C Virus Infection

American Journal of Medicine

Volumn 121, Issue 7, 2008, Pages 624-631

  Delluc, Aurélien ^a   Saadoun, David ^a   Ghillani Dalbin, Pascale ^b   Sene, Damien ^a   Piette, Jean Charles ^a   Cacoub, Patrice ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cryofibrinogen; Cryoglobulin; HCV infection; Vasculitis

Indexed keywords

ANTIVIRUS AGENT; CRYOGLOBULIN; FIBRINOGEN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING TEST; TREATMENT OUTCOME; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CRYOGLOBULINS; FEMALE; FIBRINOGENS, ABNORMAL; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RIBAVIRIN; VASCULITIS;

EID: 45849110708     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.03.011     Document Type: Article

References (33)

1. Sene D., Limal N., and Cacoub P. Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 19 (2004) 357-381
2. Gorevic P.D., Kassab H.J., Levo Y., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69 (1980) 287-308
3. Cacoub P., Fabiani F.L., Musset L., et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96 (1994) 124-132
4. Sansonno D., De Vita S., Iacobelli A.R., et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 160 (1998) 3594-3601
5. Monteverde A., Ballare M., Bertoncelli M.C., et al. Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 13 Suppl 13 (1995) S141-S147
6. Vallat L., Benhamou Y., Gutierrez M., et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 50 (2004) 3668-3678
7. Saadoun D., Landau D.A., Calabrese L.H., and Cacoub P.P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 46 (2007) 1234-1242
8. Cacoub P., Renou C., Rosenthal E., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltimore) 79 (2000) 47-56
9. Clifford B.D., Donahue D., Smith L., et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21 (1995) 613-619
10. Pawlotsky J.M., Roudot-Thoraval F., Simmonds P., et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122 (1995) 169-173
11. Cacoub P., Poynard T., Ghillani P., et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42 (1999) 2204-2212
12. De Rosa F.G., Pucillo L.P., Coviello R., et al. Influence of age and autoimmunity on liver disease in HCV-associated type II mixed cryoglobulinemia. Hum Immunol 63 (2002) 751-757
13. Zachou K., Liaskos C., Christodoulou D.K., et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 33 (2003) 161-168
14. Korst D.R., and Kratochvil C.H. Cryofibrinogen in a case of lung neoplasm associated with thrombophlebitis migrans. Blood 10 (1955) 945-953
15. Stathakis N.E., Karamanolis D., Koukoulis G., and Tsianos E. Characterization of cryofibrinogen isolated from patients plasma. Haemostasis 10 (1981) 195-202
16. Rachmilewitz E.A., Sacks M.I., and Zlotnick A. Essential cryofibrinogenemia. Clinical, pathological and immunological studies. Isr J Med Sci 6 (1970) 32-43
17. Beightler E., Diven D.G., Sanchez R.L., and Solomon A.R. Thrombotic vasculopathy associated with cryofibrinogenemia. J Am Acad Dermatol 24 2 Pt 2 (1991) 342-345
18. Jantunen E., Soppi E., Neittaanmaki H., and Lahtinen R. Essential cryofibrinogenaemia, leukocytoclastic vasculitis and chronic purpura. J Intern Med 234 (1993) 331-333
19. Zlotnick A., Shahin W., and Rachmilewitz E.A. Studies in cryofibrinogenemia. Acta Haematol 42 (1969) 8-17
20. Smith S.B., and Arkin C. Cryofibrinogenemia: incidence, clinical correlations, and a review of the literature. Am J Clin Pathol 58 (1972) 524-530
21. Robinson M.G., Troiano G., Cohen H., and Foadi M. Acute transient cryofibrinogenemia in infants. J Pediatr 69 (1966) 35-39
22. Ritzmann S.E., Levin W.C., Ivers J.B., and Koch J.L. I.Cryoproteinemias. 2. Primary cryofibrinogenemia-its association with cryopathy and telangiectasis. Tex Rep Biol Med 21 (1963) 567-580
23. Ireland T.A., Werner D.A., Rietschel R.L., et al. Cutaneous lesions in cryofibrinogenemia. J Pediatr 105 (1984) 67-69
24. Nagy J., Ambrus M., Paal M., et al. Cryoglobulinaemia and cryofibrinogenaemia in IgA nephropathy: a follow-up study. Nephron 46 (1987) 337-342
25. Meltzer M., Franklin E.C., Elias K., et al. Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40 (1966) 837-856
26. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 1 Pt 1 (1994) 15-20
27. Von Clauss A. Gerinnungsphysiologische Scnellmethod zur bestimmung des fibrinogens. Acta Haematol 17 (1957) 237-246
28. Blain H., Cacoub P., Musset L., et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol 120 (2000) 253-260
29. Sawada K., Takahashi R., Saniabadi, et al. Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous. World J Gastroenterol 12 (2006) 1621-1625
30. Wardle E.N., and Taylor G. Fibrin breakdown products and fibrinolysis in renal disease. J Clin Pathol 21 (1968) 140-146
31. Kuipers J.G., Kellett J., and May D. Low levels of cryofibrinogenaemia and peripheral circulatory dysfunction. Ir Med J 84 (1991) 68-69
32. Cacoub P., Ratziu V., Myers R.P., et al. Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 36 (2002) 812-818
33. Saadoun D., Resche-Rigon M., Thibault V., et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 54 (2006) 3696-3706